Validation and Potential Mechanisms of Red Cell Distribution Width as a Prognostic Marker in Heart Failure
To access this article, please choose from the options below
Supported by the STAMINA-HFP and UNITE-HF Biomarker registries were funded by Amgen, Inc (Thousand Oaks, CA).
PII: S1071-9164(09)01176-2
doi:10.1016/j.cardfail.2009.11.003
© 2010 Elsevier Inc. All rights reserved.
